Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Columbia University
mi
from
New York, NY
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Miriam Hospital
mi
from
Providence, RI
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Washington
mi
from
Seattle, WA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Status: Enrolling
Updated:  3/7/2018
Texas A&M University
mi
from
College Station, TX
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Eicosapentaenoic Acid and Protein Modulation to Induce Anabolism in Chronic Obstructive Pulmonary Disease (COPD): Aim 2
Status: Enrolling
Updated: 3/7/2018
Texas A&M University
mi
from
College Station, TX
Click here to add this to my saved trials
Amyloid Beta and Cognition in Parkinson Disease
The Role of Amyloid Beta in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study
Status: Enrolling
Updated:  3/7/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Amyloid Beta and Cognition in Parkinson Disease
The Role of Amyloid Beta in the Progression of Cognitive Impairment in PD: A Prospective Cohort Study
Status: Enrolling
Updated: 3/7/2018
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 006
mi
from
Little Rock, AR
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 006
mi
from
Little Rock, AR
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 012
mi
from
Los Angeles, CA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 012
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 009
mi
from
Orange, CA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 009
mi
from
Orange, CA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 005
mi
from
Washington,
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 005
mi
from
Washington,
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 014
mi
from
Spring Hill, FL
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 014
mi
from
Spring Hill, FL
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 013
mi
from
Indianapolis, IN
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 013
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 001
mi
from
Destrehan, LA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 001
mi
from
Destrehan, LA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 015
mi
from
Saint Louis, MO
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 015
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 007
mi
from
West Seneca, NY
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 007
mi
from
West Seneca, NY
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 002
mi
from
Cincinnati, OH
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 002
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 016
mi
from
West Chester, PA
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 016
mi
from
West Chester, PA
Click here to add this to my saved trials
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated:  3/8/2018
Sp1004 003
mi
from
Austin, TX
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
A Multicenter, Open-Label, 2-Group, Dose Escalation Study of Monotherapy Administration of Rotigotine in Pediatric Subjects With Idiopathic Restless Legs Syndrome
Status: Enrolling
Updated: 3/8/2018
Sp1004 003
mi
from
Austin, TX
Click here to add this to my saved trials
Methylphenidate to Improve Balance and Walking in MS
Methylphenidate to Improve Balance and Walking in MS
Status: Enrolling
Updated:  3/8/2018
Portland VA Medical Center
mi
from
Portland, OR
Methylphenidate to Improve Balance and Walking in MS
Methylphenidate to Improve Balance and Walking in MS
Status: Enrolling
Updated: 3/8/2018
Portland VA Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
Clinical Research Facility
mi
from
Los Angeles, CA
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
Clinical Research Facility
mi
from
Chapel Hill, NC
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
Clinical Research Facility
mi
from
Durham, NC
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated:  3/8/2018
mi
from
Maastricht,
A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers
A Multicenter, Postmarketing Study to Evaluate the Concentration of Certolizumab Pegol in the Breast Milk of Mothers Receiving Treatment With Cimzia® (Certolizumab Pegol)
Status: Enrolling
Updated: 3/8/2018
mi
from
Maastricht,
Click here to add this to my saved trials
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated:  3/8/2018
LSU Health Sciences Center - Shreveport
mi
from
Shreveport, LA
Safety and Efficacy Study of Doxycycline in Combination With Interferon-B-1a to Treat Multiple Sclerosis
An Open Label Trial of Safety and Efficacy of Combination Therapy With Interferon-B-1a and Oral Doxycycline in Patients With Relapsing-remitting Multiple Sclerosis (RRMS)
Status: Enrolling
Updated: 3/8/2018
LSU Health Sciences Center - Shreveport
mi
from
Shreveport, LA
Click here to add this to my saved trials
Neural Bases of Cognitive Rehabilitation for Brain Injury
Neural Bases of Cognitive Rehabilitation for Brain Injury
Status: Enrolling
Updated:  3/9/2018
Martinez Outpatient Clinic and Community Living Center, Martinez, CA
mi
from
Martinez, CA
Neural Bases of Cognitive Rehabilitation for Brain Injury
Neural Bases of Cognitive Rehabilitation for Brain Injury
Status: Enrolling
Updated: 3/9/2018
Martinez Outpatient Clinic and Community Living Center, Martinez, CA
mi
from
Martinez, CA
Click here to add this to my saved trials
The Role of HMGB-1 in Chronic Stroke
Pilot Study of the Role of HMGB-1 in Retarding Recovery in Chronic Stroke
Status: Enrolling
Updated:  3/9/2018
North Shore University Hospital
mi
from
Manhasset, NY
The Role of HMGB-1 in Chronic Stroke
Pilot Study of the Role of HMGB-1 in Retarding Recovery in Chronic Stroke
Status: Enrolling
Updated: 3/9/2018
North Shore University Hospital
mi
from
Manhasset, NY
Click here to add this to my saved trials
The Role of HMGB-1 in Chronic Stroke
Pilot Study of the Role of HMGB-1 in Retarding Recovery in Chronic Stroke
Status: Enrolling
Updated:  3/9/2018
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
The Role of HMGB-1 in Chronic Stroke
Pilot Study of the Role of HMGB-1 in Retarding Recovery in Chronic Stroke
Status: Enrolling
Updated: 3/9/2018
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Speech Therapy for Aphasia: Comparing Two Treatments
A Prospective, Controlled Study of Rehabilitation of Anomia in Aphasia
Status: Enrolling
Updated:  3/9/2018
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Speech Therapy for Aphasia: Comparing Two Treatments
A Prospective, Controlled Study of Rehabilitation of Anomia in Aphasia
Status: Enrolling
Updated: 3/9/2018
VA Puget Sound Health Care System Seattle Division, Seattle, WA
mi
from
Seattle, WA
Click here to add this to my saved trials
Effects of Carotid Stent Design on Cerebral Embolization
Effects of Carotid Stent Design on Cerebral Embolization
Status: Enrolling
Updated:  3/10/2018
Dallas VA Medical Center
mi
from
Dallas, TX
Effects of Carotid Stent Design on Cerebral Embolization
Effects of Carotid Stent Design on Cerebral Embolization
Status: Enrolling
Updated: 3/10/2018
Dallas VA Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Exercise for Swallowing Problems After Stroke
Rehabilitation Exercise for Dysphagia Subsequent to Stroke
Status: Enrolling
Updated:  3/12/2018
Wlliam S. Middleton Memorial Veterans Hospital, Madison
mi
from
Madison, WI
Exercise for Swallowing Problems After Stroke
Rehabilitation Exercise for Dysphagia Subsequent to Stroke
Status: Enrolling
Updated: 3/12/2018
Wlliam S. Middleton Memorial Veterans Hospital, Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
David Geffen School of Medicine at UCLA, UCLA Neurological Services
mi
from
Los Angeles, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
David Geffen School of Medicine at UCLA, UCLA Neurological Services
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
The Shankle Clinic
mi
from
Newport Beach, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
The Shankle Clinic
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
Memory and Aging Centre
mi
from
San Francisco, CA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
Memory and Aging Centre
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
Meridien Research
mi
from
Brooksville, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
Meridien Research
mi
from
Brooksville, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
Mayo Clinic
mi
from
Jacksonville, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
Mayo Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
Compass Research LLC
mi
from
Orlando, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
University of South Florida
mi
from
Tampa, FL
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
University of South Florida
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated:  3/12/2018
Department of Neurology, Emory University
mi
from
Atlanta, GA
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
A Double-Blind, Placebo-Controlled, Randomized, Parallel Group, 12-Month Safety and Efficacy Trial of TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
Status: Enrolling
Updated: 3/12/2018
Department of Neurology, Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials